| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/08/2001 | EP1121127A1 Oral pharmaceutical compositions containing buprenorphin |
| 08/08/2001 | EP1121123A2 Formulations of fexofenadine |
| 08/08/2001 | EP1121116A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 08/08/2001 | EP1121112A2 Storable active substance concentrate with formoterol |
| 08/08/2001 | EP1121109A2 Opioid analgesic |
| 08/08/2001 | EP1121107A2 Sertraline oral concentrate |
| 08/08/2001 | EP1121104A2 New sustained release oral formulations |
| 08/08/2001 | EP1121103A2 Orally disintegrable tablets |
| 08/08/2001 | EP1121102A1 Liposome-entrapped topoisomerase inhibitors |
| 08/08/2001 | EP1121101A1 Aerosol ointment compositions and method of manufacture |
| 08/08/2001 | EP1121100A1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 08/08/2001 | EP1121099A1 Pharmaceutical composition with gastric residence and controlled release |
| 08/08/2001 | EP1121096A1 Uv protection compositions |
| 08/08/2001 | EP1054595A4 Methods and compounds for the genetic treatment of hyperlipidemia |
| 08/08/2001 | EP1044005A4 1,2,4-benzotriazine oxides formulations |
| 08/08/2001 | EP1037647B1 Medicinal plant dry extracts |
| 08/08/2001 | EP1024792A4 Topical antifungal composition |
| 08/08/2001 | EP1019037B1 Medicament containing delta-aminolevulinic acid |
| 08/08/2001 | EP1011692A4 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY |
| 08/08/2001 | EP0965342B1 Preparation for percutaneous administration containing 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazole |
| 08/08/2001 | EP0759773B1 Lacrimal gland specific emulsions for topical application to ocular tissue |
| 08/08/2001 | EP0739197B1 Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds |
| 08/08/2001 | CN1307613A Coating and excipient agent for oral or dermal dosage forms |
| 08/08/2001 | CN1307590A Treating and diagnosing macrophage-mediated diseases using FC receptor ligands |
| 08/08/2001 | CN1307486A Pharmaceutical levothyroxine preparation |
| 08/08/2001 | CN1307483A Adjuvant and vaccine composition containing monophosphoryl lipid A |
| 08/08/2001 | CN1307475A Medicinal compositions |
| 08/08/2001 | CN1307472A Compositions comprising organic mono-or dinitrate for treating impotence |
| 08/08/2001 | CN1306862A Matrix for Chinese medicine plaster and its preparation technology |
| 08/08/2001 | CN1069214C Stabilized somatotropin for parenteral administration |
| 08/08/2001 | CN1069195C Prep. of suspendible composition |
| 08/08/2001 | CN1069193C Prep. of ointments containing tricyclic compound |
| 08/08/2001 | CN1069191C Compressed gas packagings using polyoxyethylene glyleryl oleates description |
| 08/07/2001 | US6271381 Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody |
| 08/07/2001 | US6271368 Nucleotide sequences coding moduator of cellular activities; for the use in the prevention of plant consumption; viricides |
| 08/07/2001 | US6271357 Oligonucleotide mimics having nitrogen-containing linkages |
| 08/07/2001 | US6271307 Drugs with polyether copolymers with unsaturated ester, vinyl ethers, amides or acids |
| 08/07/2001 | US6271278 Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties |
| 08/07/2001 | US6271268 Treatment of gland disorders with antisecretory agents such as acyl coa cholesterol acyl transferase(acat) inhibitors or prodrugs |
| 08/07/2001 | US6271254 Producing cytoprotective effect in a person via administering isomers of alpha-lipoic acid on carriers (stabilizers and solubilizers); useful in treating pain and inflammation |
| 08/07/2001 | US6271252 Cyclic amino acid derivatives as cell adhesion inhibitors |
| 08/07/2001 | US6271219 Topical formulations comprising skin penetration agents and the use thereof |
| 08/07/2001 | US6271212 Mixture with carrier |
| 08/07/2001 | US6271209 Cationic lipid formulation delivering nucleic acid to peritoneal tumors |
| 08/07/2001 | US6271200 Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 08/07/2001 | US6271001 Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications |
| 08/07/2001 | US6270806 Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions |
| 08/07/2001 | US6270805 Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate |
| 08/07/2001 | US6270798 Drug particles have first coating controlling the release of the drug and a second outer coating with saliva-resistant properties |
| 08/07/2001 | US6270793 Hydratable keratin solid wherein said hydratable keratin comprises keratin having sulfonic acid groups ionically associated with monovalent cations. |
| 08/07/2001 | US6270790 Mannitol, sorbitol, maltitol, dextrose, sucrose, xylitol, or lactose; cellulose, cellulosic derivatives, polyvinyl pyrrolidone, starch, ormodified starch binder |
| 08/07/2001 | US6270789 Comprising (a) oily or fatty base, (b) polyethylene and (c) polyglycerin fatty acid ester. |
| 08/07/2001 | US6270757 Formulations for IL-11 |
| 08/07/2001 | CA2145242C Oral pharmaceutical preparation |
| 08/07/2001 | CA2139217C Vaccine composition for eliciting an immune response against n-glycolylated gangliosides and its use for cancer treatment |
| 08/07/2001 | CA2045883C Process for the extrusion preparation of actives granules |
| 08/02/2001 | WO2001055391A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 08/02/2001 | WO2001055385A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/02/2001 | WO2001055360A1 Slow release protein polymers |
| 08/02/2001 | WO2001055220A1 Chitosan condensation products, their preparation and their uses |
| 08/02/2001 | WO2001055216A1 Methods and compositions for generating human monoclonal antibodies |
| 08/02/2001 | WO2001055158A1 Azalide antibiotic compositions |
| 08/02/2001 | WO2001055151A1 Polymeric micellar structure |
| 08/02/2001 | WO2001055098A1 Palatable arginine compounds and uses thereof for cardiovascular health |
| 08/02/2001 | WO2001055092A2 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 08/02/2001 | WO2001054748A1 Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia |
| 08/02/2001 | WO2001054744A1 Transdermal thermal polymerization |
| 08/02/2001 | WO2001054741A1 A medicinal aerosol formulation |
| 08/02/2001 | WO2001054732A1 Antibodies against ctla4 (cd152), conjugates comprising same, and uses thereof |
| 08/02/2001 | WO2001054730A1 METHOD FOR PRODUCING A COENZYME Q10 / η-CYCLODEXTRIN COMPLEX |
| 08/02/2001 | WO2001054727A1 Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes |
| 08/02/2001 | WO2001054720A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| 08/02/2001 | WO2001054709A1 Vzv orf29p protein-related compositions and methods |
| 08/02/2001 | WO2001054687A1 Ophthalmic anti-allergy compositions suitable for use with contact lenses |
| 08/02/2001 | WO2001054686A2 L-arginine in combination with other compounds for treating cardiovascular diseases |
| 08/02/2001 | WO2001054685A1 Mucin synthesis inhibitors |
| 08/02/2001 | WO2001054683A1 Ibuprofen containing active agent preparation |
| 08/02/2001 | WO2001054675A2 Pharmaceutical compositions comprising terbinafine |
| 08/02/2001 | WO2001054669A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |
| 08/02/2001 | WO2001054668A1 Pharmaceutical compositions comprising a hmg reductase inhibitor |
| 08/02/2001 | WO2001054667A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | WO2001054663A2 Surfactant free topical compositions and method for rapid preparation thereof |
| 08/02/2001 | WO2001054662A2 Compressed microparticles for dry injection |
| 08/02/2001 | WO2001054647A2 Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase |
| 08/02/2001 | WO2001054514A1 Composition for intestinal delivery |
| 08/02/2001 | WO2001019329A3 Polyoxyalkylene copolymers containing pourable liquid vehicles |
| 08/02/2001 | WO2001012797A3 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 08/02/2001 | WO2001007065A3 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 08/02/2001 | WO2000076453A3 Emzyme-assisted cell death |
| 08/02/2001 | WO2000069887A3 Rapid dehydration of proteins |
| 08/02/2001 | WO2000067801A3 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/02/2001 | WO2000066175A3 Conjugates as therapies for cancer and prostate diseases |
| 08/02/2001 | WO2000064483A3 Releasable linkage and compositions containing same |
| 08/02/2001 | WO2000053230A3 Surface modification of lamellar particles |
| 08/02/2001 | US20010011115 Poly (ethylene glycol) derivatives with proximal reactive groups |
| 08/02/2001 | US20010011082 Mixture with chelate compound; bone disorders |
| 08/02/2001 | US20010011071 Polypeptide drug; antidiabetic agent |
| 08/02/2001 | US20010010920 Complex of rapamycin-42 ester with dicarboxylic acid and fluorescein; antibody detection/generation; immunoglobulins; hybridomas; ring opening; precipitation |
| 08/02/2001 | US20010010826 Contacting the site of wound with a matrix comprising gelatin and a nitric oxide scavanger to increase blood cirulation; nitric oxide scavanger are selected from L-arganine analog, dextran, heparin, cysteine and cystine |
| 08/02/2001 | US20010010825 Rapidly disintegrable solid preparation |